Intec…today announced that the pending and previously announced reverse merger with Decoy Biosystems, Inc. is currently expected to close after market hours today, Tuesday, August 3, 2021, subject to satisfaction or waiver of all closing conditions.
Immediately following the closing, the combined company will be renamed "Indaptus Therapeutics, Inc.", and is expected to begin trading on The Nasdaq Capital Market under the new ticker symbol "INDP" upon the commencement of trading on Wednesday, August 4, 2021.
This overrides the info from a PR last week that said the NTEC symbol would be retained.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”